Current Report Filing (8-k)
July 23 2018 - 8:10AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
July 17, 2018
Blonder
Tongue Laboratories, Inc.
(Exact
Name of registrant as specified in its charter)
Delaware
|
|
1-14120
|
|
52-1611421
|
(State
or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification No.)
|
One
Jake Brown Road, Old Bridge, New Jersey
08857
(Address of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code:
(732) 679-4000
Not Applicable
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
5.02
|
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
On
July 17, 2018, the board of directors of Blonder Tongue Laboratories, Inc. (the “Company”) determined to reassign
Nezam Nikoo from his duties as the Company’s Vice President – Engineering, Chief Technical Officer. Based on this
determination, Mr. Nikoo will no longer be serving as an executive officer of the Company.
Item
7.01
|
|
Regulation FD Disclosure
|
On
July 23, 2018, the Company issued a press release announcing the appointment of Ronald Alterio as Vice President – Engineering,
Chief Technology Officer. That press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated
herein by reference.
Item
9.01
|
|
Financial Statements and Exhibits
|
(d) Exhibits.
The following exhibit is filed herewith:
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
BLONDER
TONGUE LABORATORIES, INC.
|
|
|
|
|
By:
|
/s/
Eric Skolnik
|
|
|
Eric
Skolnik
|
|
|
Senior
Vice President and Chief Financial Officer
|
Date:
July 23, 2018
EXHIBIT
INDEX
3
Blonder Tongue Laborator... (AMEX:BDR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Blonder Tongue Laborator... (AMEX:BDR)
Historical Stock Chart
From Sep 2023 to Sep 2024